References
- Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome – structure and function. Arch. Ophthalmol.108, 1408–1416 (1990).
- The Photographic Screening for Retinopathy of Prematurity Cooperative Group. The photographic screening for retinopathy of prematurity study: primary outcomes. Retina28, S47–S54 (2008).
- Silverman W. Retrolental fibroplasia: a modern parable. Grune and Stratton, NY, USA (1980).
- Terry TL. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens. I. Preliminary report. Am. J. Ophthalmol.25, 203–204 (1942).
- Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch. Ophthalmol.121(12), 1684–1694 (2003).
- Section on Ophthalmology American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics117(2), 572–576 (2006).
- Canadian Association of Pediatric Ophthalmologists Ad Hoc Committee on Standards of Screening Examination for Retinopathy of Prematurity. Guidelines for screening examination for retinopathy of prematurity. Can. J. Ophthalmol.35, 251–252 (2000).
- No authors listed. Retinopathy of prematurity: guidelines for screening and treatment. The report of a joint working party of the Royal College of Ophthalmologists and the British Association of Perinatal Medicine. Early Hum. Dev.46, 239–258 (1996).
- Schaffer DB, Tung B, Hardy RJ. Guidelines for follow-up of retinopathy of prematurity. In: Retinopathy of Prematurity: A Clinician’s Guide. Flynn JT, Tasman W (Eds). Springer-Verlag, NY, USA, 45–53 (1992).
- Ells A, Hindle W. Commentary on guidelines for screening for retinopathy of prematurity. Can. J. Ophthalmol.35, 253–254 (2000).
- Hardy RJ, Palmer EA, Schaffer DB et al. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity Cooperative Group. Outcome-based management of retinopathy of prematurity. J. AAPOS1, 46–54 (1997).
- Dunbar JA, Hsu V, Christensen M, Black B, Williams P, Beauchamp G. Cost–utility analysis of screening and laser treatment of retinopathy of prematurity. J AAPOS13, 186–190 (2009).
- Day S, Menke AM, Abbott RL. Retinopathy of prematurity malpractice claims: the ophthalmic mutual insurance company experience. Arch. Ophthalmol.127(6), 794–798 (2009).
- Reynolds JD. Malpractice and the quality of care in retinopathy of prematurity (an American Ophthalmological Society thesis). Trans. Am. Ophthalmol. Soc.105, 461–480 (2007).
- Ells AL, Holmes JM, Astle WF et al. Telemedicine approach to screening for severe retinopathy of prematurity – a pilot study. Ophthalmology110, 2113–2117 (2003).
- Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case–control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology107(12), 2224–2232 (2000).
- Azen SP, Irvine AR, Davis MD et al. The validity and reliability of photographic documentation of proliferative vitreoretinopathy. Ophthalmology96(3), 352–357 (1989).
- Pugh JA, Jacobson JM, Van Heuven WA et al. Screening for diabetic retinopathy. The wide-angle retinal camera. Diabetes Care16(6), 889–895 (1993).
- International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch. Ophthalmol.123, 991–999 (2005).
- Morizane H. Initial sign and clinical course of the most severe form of acute proliferative retrolental fibroplasias (type 1) [in Japanese]. Nippon Ganka Gakkai Zasshi80, 54–61 (1976).
- Quiram PA, Capone A Jr. Current understanding and management of retinopathy of prematurity. Curr. Opin. Ophthalmol.18, 228–234 (2007).
- Attar MA, Gates MR, Iatrow AM, Lang SW, Bratton SL. Barriers to screening infants for retinopathy of prematurity after discharge or transfer from a neonatal intensive care unit. J. Perinatol.25(1), 36–40 (2005).
- Aprahamian AD, Coats DK, Paysse EA, Brady-McCreery K. Compliance with outpatient follow-up recommendations for infants at risk for retinopathy of prematurity. J. AAPOS4(5), 282–286 (2000).
- Richter GM, Sun G, Lee TC et al. Speed of telemedicine vs. ophthalmoscopy for retinopathy of prematurity diagnosis. Am. J. Ophthalmol.148, 136–142 (2009).
Websites
- Survey: physicians being driven away from ROP treatment. Ocular Surgery News www.osnsupersite.com/view.asp?rID=18018
- FocusROP™ website www.FocusROP.com
- Public Law No. 102–539 HR 6182. Title: To amend the Public Health Service Act to establish the authority for the regulation of mammography services and radiological equipment, and for other purposes. Sponsor: Rep Dingell, John D. [MI-16] (introduced 10/6/1992). Latest Major Action: 10/27/1992 Became Public Law No: 102–539 http://thomas.loc.gov/cgi-bin/bdquery/z?d102:HR06182
- ROPARD: The Association for Retinopathy of Prematurity and Related Diseases www.ropard.org